{"id":48057,"date":"2022-09-07T14:02:13","date_gmt":"2022-09-07T12:02:13","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/"},"modified":"2022-09-07T14:02:13","modified_gmt":"2022-09-07T12:02:13","slug":"arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/","title":{"rendered":"Arpeggio Biosciences Raises $17 Million in Series A Funding Led by Builders VC"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\n<i>New capital will support ongoing development of their drug pipeline targeting transcriptional mechanisms in disease<\/i>\n<\/li>\n<li>\n<i>Arpeggio\u2019s technology isolates a drug\u2019s effect on entire transcriptomes and has identified new modulators of hard-to-drug proteins like transcription factors<\/i>\n<\/li>\n<li>\n<i>To date, Arpeggio has contracted with more than 40 pharmaceutical companies to assess the impact of diverse classes of molecules on cellular transcription<\/i>\n<\/li>\n<\/ul>\n<p>BOULDER, Colo. &amp; SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Arpeggio Biosciences, a preclinical therapeutics company whose technology targets transcriptional dysregulation in disease, and Builders VC, today announced a $17 million dollar Series A funding round, following a $3.2 million dollar seed round completed in 2020. Funding was led by Builders VC and will support ongoing development of Arpeggio\u2019s drug pipeline as well as its transcription-monitoring technologies.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220907005277\/en\/1562800\/5\/Standard_Arpeggio_Logo_-_Light_Background_copy.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220907005277\/en\/1562800\/21\/Standard_Arpeggio_Logo_-_Light_Background_copy.jpg\"><\/a><\/p>\n<p>\n\u201cThis Series A funding will enable us to continue our mission of discovering new therapies for diseases arising through dysregulation of transcription,\u201d said Joey Azofeifa, Ph.D., Founder and CEO, Arpeggio. \u201cOur platform screens drug libraries for their effect on thousands of gene and non-coding transcripts, allowing for the first time, the design of molecules to modulate not just a single target, but a cell\u2019s entire transcriptome.\u201d\n<\/p>\n<p>\n\u201cBy building technology capable of screening hundreds of thousands of compounds, we feel well-positioned to discover novel modulators of high value targets considered \u2018undruggable\u2019 such as transcription factors,\u201d Azofeifa continued.\n<\/p>\n<p>\nArpeggio\u2019s technology reads out on transcription directly and can monitor the activity of more than 100,000 transcripts across diseased and healthy cells exposed to diverse stimuli such as small molecules, biologics, or ASOs. Using machine learning, Arpeggio reconstructs the biological networks affected by the molecule and matches the molecule to diseases where the compound could be therapeutically relevant.\n<\/p>\n<p>\n\u201cHealthcare is primed to benefit from a disrupting system like Arpeggio\u2019s, which has so much potential to help further our understanding of how drugs interact with each individual taking them,\u201d said Amit Mehta, MD, General Partner of Builders VC. \u201cWe believe Arpeggio has the vision to transform the way we approach drug and therapy development.\u201d\n<\/p>\n<p>\nThis Series A funding was also supported by Arpeggio\u2019s seed round investors: Khosla Ventures, TechU Ventures, FundersClub, Alice Zhang, and Fifty Years, with new participation from Tencent, ATEM Capital, Formic Ventures, Tau Ventures, Milad Alucozai (BoxOne Ventures), and Matthew De Silva (Longtail Capital).\n<\/p>\n<p>\n<b>About Arpeggio Bio<\/b>\n<\/p>\n<p>\nEstablished in 2018, Arpeggio\u2019s proprietary platform \u2013 developed by co-founders and Chief Executive Officer Joey Azofeifa, Chief Technology Officer Tim Read, and Chief Operating Officer Laura Norris \u2013 has built the largest database of nascent-RNA sequences in the world. Arpeggio&#8217;s technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug\u2019s function and guide therapeutic development. To learn more, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.arpeggiobio.com%2F&amp;esheet=52860753&amp;newsitemid=20220907005277&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.arpeggiobio.com%2F&amp;index=1&amp;md5=948076152f60ffea394d432118e4f208\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.arpeggiobio.com\/<\/a>\n<\/p>\n<p>\n<b>About Builders VC<\/b>\n<\/p>\n<p>\nBuilders VC is an early-stage venture capital firm focused on investing where technology meets new business models to modernize antiquated industries including healthcare, agriculture, industrial, and real-estate. Visit: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.builders.vc%2F&amp;esheet=52860753&amp;newsitemid=20220907005277&amp;lan=en-US&amp;anchor=www.builders.vc&amp;index=2&amp;md5=49151e6997be2f5ece2984768a321355\" rel=\"nofollow noopener\" shape=\"rect\">www.builders.vc<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nJulie Ferguson<br \/>\n<br \/>312.385.0098<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#105;&#x6c;&#x74;&#x6f;:j&#102;&#101;&#x72;&#x67;&#x75;s&#111;&#110;&#64;&#x63;&#x67;&#x6c;i&#102;&#101;&#x2e;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">j&#102;&#101;&#x72;&#x67;&#x75;&#x73;o&#110;&#64;&#99;&#x67;&#x6c;&#x69;fe&#46;&#99;&#x6f;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>New capital will support ongoing development of their drug pipeline targeting transcriptional mechanisms in disease Arpeggio\u2019s technology isolates a drug\u2019s effect on entire transcriptomes and has identified new modulators of hard-to-drug proteins like transcription factors To date, Arpeggio has contracted with more than 40 pharmaceutical companies to assess the impact of diverse classes of molecules &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48057","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Arpeggio Biosciences Raises $17 Million in Series A Funding Led by Builders VC - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arpeggio Biosciences Raises $17 Million in Series A Funding Led by Builders VC - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"New capital will support ongoing development of their drug pipeline targeting transcriptional mechanisms in disease Arpeggio\u2019s technology isolates a drug\u2019s effect on entire transcriptomes and has identified new modulators of hard-to-drug proteins like transcription factors To date, Arpeggio has contracted with more than 40 pharmaceutical companies to assess the impact of diverse classes of molecules ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-07T12:02:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220907005277\/en\/1562800\/21\/Standard_Arpeggio_Logo_-_Light_Background_copy.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Arpeggio Biosciences Raises $17 Million in Series A Funding Led by Builders VC\",\"datePublished\":\"2022-09-07T12:02:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\\\/\"},\"wordCount\":521,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907005277\\\/en\\\/1562800\\\/21\\\/Standard_Arpeggio_Logo_-_Light_Background_copy.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\\\/\",\"name\":\"Arpeggio Biosciences Raises $17 Million in Series A Funding Led by Builders VC - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907005277\\\/en\\\/1562800\\\/21\\\/Standard_Arpeggio_Logo_-_Light_Background_copy.jpg\",\"datePublished\":\"2022-09-07T12:02:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907005277\\\/en\\\/1562800\\\/21\\\/Standard_Arpeggio_Logo_-_Light_Background_copy.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907005277\\\/en\\\/1562800\\\/21\\\/Standard_Arpeggio_Logo_-_Light_Background_copy.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arpeggio Biosciences Raises $17 Million in Series A Funding Led by Builders VC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Arpeggio Biosciences Raises $17 Million in Series A Funding Led by Builders VC - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/","og_locale":"en_US","og_type":"article","og_title":"Arpeggio Biosciences Raises $17 Million in Series A Funding Led by Builders VC - Pharma Trend","og_description":"New capital will support ongoing development of their drug pipeline targeting transcriptional mechanisms in disease Arpeggio\u2019s technology isolates a drug\u2019s effect on entire transcriptomes and has identified new modulators of hard-to-drug proteins like transcription factors To date, Arpeggio has contracted with more than 40 pharmaceutical companies to assess the impact of diverse classes of molecules ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-07T12:02:13+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220907005277\/en\/1562800\/21\/Standard_Arpeggio_Logo_-_Light_Background_copy.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Arpeggio Biosciences Raises $17 Million in Series A Funding Led by Builders VC","datePublished":"2022-09-07T12:02:13+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/"},"wordCount":521,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220907005277\/en\/1562800\/21\/Standard_Arpeggio_Logo_-_Light_Background_copy.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/","url":"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/","name":"Arpeggio Biosciences Raises $17 Million in Series A Funding Led by Builders VC - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220907005277\/en\/1562800\/21\/Standard_Arpeggio_Logo_-_Light_Background_copy.jpg","datePublished":"2022-09-07T12:02:13+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220907005277\/en\/1562800\/21\/Standard_Arpeggio_Logo_-_Light_Background_copy.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220907005277\/en\/1562800\/21\/Standard_Arpeggio_Logo_-_Light_Background_copy.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/arpeggio-biosciences-raises-17-million-in-series-a-funding-led-by-builders-vc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Arpeggio Biosciences Raises $17 Million in Series A Funding Led by Builders VC"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48057"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48057\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}